Related Experiment Video
Updated: Oct 19, 2025

Murine Kidney Transplant Technique
Published on: October 20, 2015
ST elevation myocardial infarction and kidney transplant: A large cohort study: STEMI and renal transplant
Tanveer Mir1, Mohammed Uddin1, Asif Shah2
1Internal Medicine, Detroit Medical Center Wayne State University, Detroit, MI, United States.
Insights
ST-elevation myocardial infarction (STEMI) is a significant complication in kidney transplant recipients (KTR), leading to higher mortality and mechanical complications. Improving cardiovascular risk factors may reduce STEMI incidence in this population.
Area of Science:
- Cardiology
- Nephrology
- Transplantation Medicine
Background:
- Limited literature exists on the outcomes of ST-elevation myocardial infarction (STEMI) specifically within the kidney transplant recipient (KTR) population.
- STEMI represents a critical cardiovascular event with potentially distinct implications for KTR due to their unique physiological state.
Purpose of the Study:
- To investigate the incidence, in-hospital outcomes, and complications associated with STEMI among kidney transplant recipients (KTR).
- To evaluate the impact of percutaneous coronary intervention (PCI) on mortality in KTR experiencing STEMI.
Main Methods:
- Analysis of the National Readmissions Database (NRD) from 2012-2018, including 588,668 KTR hospitalizations.
- Extraction of STEMI cases and associated complications using International Classification of Diseases codes.
- Utilized coarsened exact matching to assess the association between PCI and mortality.
Main Results:
- STEMI occurred in 0.59% of KTR hospitalizations, with significantly higher in-hospital mortality (13.3%) compared to non-STEMI cases (1.92%).
- STEMI patients experienced increased rates of mechanical complications, cardiogenic shock, ventricular arrhythmias, conduction blocks, stroke, and acute kidney injury.
- Percutaneous coronary intervention (PCI) was associated with reduced mortality (OR 0.39; p=0.0002), while STEMI incidence decreased and PCI utilization increased over the study period.
Conclusions:
- STEMI is a notable complication in KTR, frequently associated with severe mechanical complications and increased mortality.
- While STEMI rates have shown a decreasing trend, proactive management of cardiovascular risk factors is crucial for mitigating STEMI incidence and improving outcomes in KTR.
Background:
The literature on outcomes of ST-elevation myocardial infarction (STEMI) amongst kidney transplant recipients (KTR) is limited.
Objective:
To study the outcomes of STEMI among KTR.
Methods:
Data from the national readmissions database (NRD) sample that constitutes 49.1% of the stratified sample of all hospitals in the USA were analyzed for hospitalizations with STEMI among KTR for the years 2012-2018. Complications associated with STEMI were extracted using International Classification of Diseases codes.
Results:
A total of 588,668 index KTR hospitalizations (mean age 57.67±14.22 years; female 44.5%) of which 3,496 (0.59%) had STEMI were recorded in the NRD for the years 2012-2018. A total of 11,676 (1.98%) patients died during the hospitalization. In-hospital mortality among STEMI was higher, 465 (13.3%), than without-STEMI 11,211 (1.92%). Among the complications, mechanical complications occurred among 1.0% vs 0.02%, cardiogenic shock 10.6 vs 0.3%, ventricular arrythmias 8.3% vs 0.8%, conduction block 6.9% vs 2%, stroke 4.1% vs 1.9%, and acute kidney injury 31.6% vs 28.3% among STEMI and without-STEMI respectively. Among coronary procedures, coronary angiography was performed among 1,999 (57.2%) of which 1,777 (50.8%) had percutaneous coronary intervention (PCI). On coarsened exact matching of baseline characteristics, PCI was less likely associated with mortality, odds ratio 0.39 (95% confidence interval 0.24-0.64; p=0.0002). The trends of mortality among STEMI were steady (p-trend 0.11). PCI trend increased (p-trend 0.008) and incidence of STEMI decreased over the study years 2012 (0.66%)-2018(0.474%). A total of 84,810 (14.4%) patients were readmitted in 30 days of which 696 (20%) patients were among the STEMI subgroup.
Conclusion:
STEMI is not an uncommon complication among KTR and is associated with significant mechanical complications. Improvement in cardiovascular risk factors might improve the STEMI rates among KTR.
Related Concept Videos
Kidney Transplant I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management
Acute Kidney Injury I: Introduction
Acute Kidney Injury II: Pathophysiology

